Vitamin-E-based treatment for Alzhemer’s disease: α-Tocopherol promotes the clearance of phosphorated tau protein via induction of autophagy adaptor protein NDP52, 4/July/2014, 13.22

Vitamin-E-based treatment for Alzhemer’s disease: α-Tocopherol promotes the clearance of phosphorated tau protein via induction of autophagy adaptor protein NDP52, 4/July/2014, 13.22

Vitamin-E-based treatment for Alzhemer’s disease: α-Tocopherol promotes the clearance of phosphorated tau protein via induction of autophagy adaptor protein NDP52, 4/July/2014, 13.22 150 150 Dr Boomi's Genom-2-Discovery Center

Prof. Dr. Johnson, Jo, and others from  the Department of Anesthesiology, University of Rochester Medical Center, University of Rochester,  New York, USA report in the prestigious journal Nature Communications (2014) that “Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52”

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMDreports that: Vitamin-E-based treatment for Alzhemer’s disease: α-Tocopherol promotes the clearance of phosphorated tau protein via induction of autophagy adaptor protein NDP52.

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan,  Vitamin-E-based treatment for Alzhemer’s disease: α-Tocopherol promotes the clearance of phosphorated tau protein via induction of autophagy adaptor protein NDP52,  4/July/2014, 13.23, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation